𝔖 Bobbio Scriptorium
✦   LIBER   ✦

13. Immunogenetherapy combined with brain metastases irradiation in melanoma patients

✍ Scribed by S. Nawrocki; A. Karczewska; P. Milecki; D. Iżycki; G. Stryczyńska; A. Mackiewicz

Book ID
104440961
Publisher
Wielkopolskie Centrum Onkologii
Year
2001
Tongue
Polish
Weight
119 KB
Volume
6
Category
Article
ISSN
1507-1367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biochemotherapy of metastatic melanoma i
Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases
✍ Martin Majer; Randy L. Jensen; Dennis C. Shrieve; Gordon A. Watson; Michael Wang 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract ## BACKGROUND. Brain metastases are an alarming complication of advanced melanoma, frequently contributing to patient demise. The authors performed a retrospective analysis to determine whether the treatment of metastatic melanoma with biochemotherapy would result in similar outcomes i

Temozolomide plus thalidomide in patient
Temozolomide plus thalidomide in patients with brain metastases from melanoma : A Phase II study
✍ Wen-Jen Hwu; Eric Lis; Jennifer H. Menell; Katherine S. Panageas; Lynne A. Lamb; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

## Abstract ## BACKGROUND Temozolomide plus thalidomide is a promising oral combination regimen for the treatment of metastatic melanoma. The current Phase II study examined the efficacy and safety of this combination in chemotherapy‐naive patients with brain metastases. ## METHODS Patients with